InvestorsHub Logo
Followers 0
Posts 4010
Boards Moderated 0
Alias Born 07/26/2006

Re: None

Friday, 05/27/2011 4:49:33 PM

Friday, May 27, 2011 4:49:33 PM

Post# of 320
"The recognition in our label of the DIFICID superiority in sustained clinical response will allow the Optimer and Cubist field force to educate the medical community about the advantage DIFICID can offer to appropriate CDAD patients."